Trial Profile
Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Carmustine polifeprosan 20 wafer (Primary)
- Indications Glioma
- Focus Adverse reactions
- Sponsors Eisai Co Ltd
- 29 Dec 2016 Status changed from active, no longer recruiting to completed.
- 27 Nov 2014 New trial record